Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Xinhui Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4782-3982; OpenAlex author ID A5006372579. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2024: 1 paper · 2025: 3 papers · 2026: 3 papers

Papers 7

  1. Radiosynthesis and Preclinical Evaluation of [68Ga]Ga-NOTA-PTP Profiling Plectin-1 Expression for Pancreatic Cancer Imaging. Last author DOI 10.1021/acs.jmedchem.5c02777↗
  2. Systemic Treatment Followed by Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer: A Retrospectively Observa… Co-author DOI 10.1097/sla.0000000000006600↗
  3. [18F]AlF-NOTA-FAPI-04 PET/CT outperforms contrast-enhanced CT and contrast-enhanced MRI in clinical staging evaluation of patients with initial pancreatic canc… Last author DOI 10.1186/s40644-026-01055-3↗
  4. Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Duct… Last author DOI 10.1002/mco2.70136↗
  5. Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma rece… Last author DOI 10.1007/s00259-025-07084-7↗
  6. [18F]FAPI- 04 PET/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment. Co-author DOI 10.1007/s00259-025-07271-6↗
  7. 18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.2967/jnumed.123.266283↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lili Lin · 3 shared papers, 2024–2025 · strength 0.72
  2. Yafei Zhang · 2 shared papers, 2025 · strength 0.56
  3. Xiang Li · 2 shared papers, 2024–2026 · strength 0.46
  4. Tingbo Liang · 2 shared papers, 2024–2026 · strength 0.46
  5. Xueli Bai · 2 shared papers, 2024–2026 · strength 0.46
  6. Lili Lin · 1 shared paper, 2026 · strength 0.29
  7. Tingting Wang · 1 shared paper, 2026 · strength 0.28
  8. Guoliang Qiao · 1 shared paper, 2026 · strength 0.26
  9. Tao Ma · 1 shared paper, 2026 · strength 0.26
  10. Qi Zhang · 1 shared paper, 2026 · strength 0.26
  11. Tianan Jiang · 1 shared paper, 2026 · strength 0.26
  12. Xiang Li · 1 shared paper, 2025 · strength 0.22
  13. Kang Sun · 1 shared paper, 2025 · strength 0.22
  14. Tingbo Liang · 1 shared paper, 2025 · strength 0.22
  15. Xueli Bai · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.